Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists
Giulia Bendotti, Laura Montefusco, Maria Elena Lunati, et al.
Pharmacological Research (2022) Vol. 182, pp. 106320-106320
Closed Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity
Chang H. Kim
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 4, pp. 341-350
Closed Access | Times Cited: 134
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 97
Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent
Syed Faizan Mehdi, Suma Pusapati, Muhammad Saad Anwar, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 96
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications
Saleh Hadi Alharbi
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access | Times Cited: 70
GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity
Lindsey Wang, William Yang Wang, David C. Kaelber, et al.
JAMA Oncology (2023) Vol. 10, Iss. 2, pp. 256-256
Open Access | Times Cited: 60
Leptin Increases: Physiological Roles in the Control of Sympathetic Nerve Activity, Energy Balance, and the Hypothalamic–Pituitary–Thyroid Axis
Davide Martelli, Virginia L. Brooks
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2684-2684
Open Access | Times Cited: 49
Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
Ming Li, Mengjie Wang, Yuanjia Wen, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 47
Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies
Alexis Elias Malavazos, Gianluca Iacobellis, Elena Dozio, et al.
European Journal of Preventive Cardiology (2023) Vol. 30, Iss. 8, pp. 680-693
Open Access | Times Cited: 42
Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes
Lindsey Wang, Nathan A. Berger, David C. Kaelber, et al.
Gastroenterology (2024) Vol. 167, Iss. 4, pp. 689-703
Open Access | Times Cited: 39
Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule
Moufida Ben Nasr, Vera Usuelli, Sergio Dellepiane, et al.
Cell Metabolism (2024) Vol. 36, Iss. 6, pp. 1302-1319.e12
Closed Access | Times Cited: 27
Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US
William Yang Wang, QuangQiu Wang, Xin Qi, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 19
The potential of short-chain fatty acid epigenetic regulation in chronic low-grade inflammation and obesity
Julia Kopczyńska, Magdalena Kowalczyk
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network
David García‐Vega, David Sánchez-López, Gemma Rodríguez-Carnero, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
The growing range of complications of diabetes mellitus
Peter Shane Hamblin, Anthony Russell, Stella Talic, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access | Times Cited: 2
Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
Yolanda Diz-Chaves, Zainab Mastoor, Carlos Spuch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9583-9583
Open Access | Times Cited: 45
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
Merlin C. Thomas, Melinda T. Coughlan, Mark E. Cooper
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 253-273
Open Access | Times Cited: 33
Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease
Adriana Petrazzuolo, Gianmarco Sabiu, Emma Assi, et al.
Pharmacological Research (2023) Vol. 190, pp. 106710-106710
Open Access | Times Cited: 29
Does Semaglutide Use Decrease Complications and Costs Following Total Knee Arthroplasty?
Matthew L. Magruder, Vincent J.H. Yao, Ariel N. Rodriguez, et al.
The Journal of Arthroplasty (2023) Vol. 38, Iss. 11, pp. 2311-2315.e1
Closed Access | Times Cited: 28
Once‐weekly semaglutide use in patients with type 2 diabetes: Real‐world data from the SURE Italy observational study
Raffaele Napoli, Cesare Berra, Andrei‐Mircea Catarig, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 6, pp. 1658-1667
Open Access | Times Cited: 25
Exploring the underlying mechanisms of obesity and diabetes and the potential of Traditional Chinese Medicine: an overview of the literature
Yan-Kun Chen, Tingting Liu, Farah Khameis Farag Teia, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 25
Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity
Sara De Nucci, Caterina Bonfiglio, Rosanna Donvito, et al.
Nutrients (2023) Vol. 15, Iss. 20, pp. 4468-4468
Open Access | Times Cited: 25
The impact of dietary fructose on gut permeability, microbiota, abdominal adiposity, insulin signaling and reproductive function
Ceren Güney, Nur Banu Bal, Fatma Akar
Heliyon (2023) Vol. 9, Iss. 8, pp. e18896-e18896
Open Access | Times Cited: 23
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach
Davide Arillotta, Giuseppe Floresta, Guy Pelletier, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 617-617
Open Access | Times Cited: 15
Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group
Andrej Janež, Emir Muzurović, Paweł Bogdański, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 9, pp. 1865-1892
Open Access | Times Cited: 15
Anti-inflammatory benefits of semaglutide: State of the art
Habib Yaribeygi, Mina Maleki, Tannaz Jamialahmadi, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 36, pp. 100340-100340
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top